<DOC>
	<DOCNO>NCT01867060</DOCNO>
	<brief_summary>This propsective study aim compare diagnostic yield Personal Heart Rhythm Monitor ( PHRM ) automate cardiac event recorder ( ACER ) detect paroxysmal Atrial Fibrillation PAF ) . The investigator hypothesise PHRM , use intermittently 3 month , detect significantly case PAF ACER , use continuously one week . A case-control sub-study identify individual confirm PAF , match individual evidence PAF , identify potential serum biomarkers PAF . A case-control study ass marker leave atrial function patient PAF match control . Another case-control sub-study determine significance frequent Atrial Premature Beats ( APBs ) development AF one year period .</brief_summary>
	<brief_title>Using Personal Heart Rhythm Monitor Diagnose Paroxsymal Atrial Fibrillation Community</brief_title>
	<detailed_description>Patients suspect AF initially refer community-based , nurse-led Arrhythmia clinic General Practitioners 15-month period . All patient issue one week ACER ( ' R . Test 4 Evolution ' ) , see 'best-practice ' investigation population group . Participants also issue PHRM three month . They instruct take regular twice-daily , 30 second recording additional recording event relevant symptom . They return ACER one week PHRM 3 month . A subgroup participant ( target recruitment number = 100 ) undergo transthoracic echocardiography . A 40ml venous blood sample also take . Another small subgroup ( target recruitment = 20 ) ask continue twice-daily recording use PHRM nine month issue repeat one week ACER study completion .</detailed_description>
	<mesh_term>Atrial Fibrillation</mesh_term>
	<criteria>Suspected paroxysmal AF ( either palpitation consistent AF irregular pulse ) 12lead rest ECG confirm sinus rhythm Capacity consent study Englishspeaking Life expectancy least one year Previous diagnosis AF Recent history syncope Recent history cardiacsounding chest pain A resting ECG suggestive alternative arrhythmia Inability use telephone Thyrotoxicosis</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Cardiac monitoring</keyword>
	<keyword>Biomarkers</keyword>
	<keyword>Transthoracic echocardiography</keyword>
</DOC>